trimethadione has been researched along with Autoimmune Diseases in 2 studies
Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, H | 1 |
| Booker, HE | 1 |
| Chun, RW | 1 |
| Sanguino, M | 1 |
2 other studies available for trimethadione and Autoimmune Diseases
| Article | Year |
|---|---|
Association of trimethadione therapy and myasthenia gravis.
Topics: Anticonvulsants; Autoimmune Diseases; Child; Epilepsy, Absence; Female; Humans; Myasthenia Gravis; T | 1966 |
Myasthenia gravis syndrome associated with trimethadione.
Topics: Anticonvulsants; Autoimmune Diseases; Child; Drug Hypersensitivity; Epilepsy, Absence; Female; Human | 1970 |